Course Description
Clozapine is the only evidence-based antipsychotic option for treatment-resistant schizophrenia and patients with schizophrenia and suicidality. However, using it demands regular monitoring of a patients' clozapine blood level. The faculty will discuss how a rapid clozapine blood level can improve managing patients' care and how to interpret values against the patient's response and tolerability. Professor Taylor will share his 30 years of experience working with clozapine, implementing a rapid clozapine blood test and blood level guidance that he provides within the South London and Maudsley Trust.
Faculty
View biographical information
Professor David Taylor, PhD, FRPharmS, FRCPsych(Hon)
Director of Pharmacy and Pathology
South London and Maudsley NHS Foundation Trust, London, UK
Professor of Psychopharmacology
Institute of Pharmaceutical Science, King’s College, London, UK
Editor-in-Chief
Therapeutic Advances in Psychopharmacology
Jonathan G. Leung, PharmD, BCPS, BCPP
Pharmacist
Department of Pharmacy, Mayo Clinic, Rochester, MN
Megan Ehret, PharmD, MS, BCPP
Professor
Department of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy
SMI Adviser, Pharmacist Consultant
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.